Evidence map›Paper›PMID 31613681›Full record

ArticlePharmaceutical biology2019

K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3

Ziming Cheng, Xiufeng Li, Shizhen Hou, Yubing Wu, Yi Sun, Bing Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. The dark side of SIRT7.Molecular and cellular biochemistry · 2024
    Review
  4. Article
  5. Roles of sirtuins in asthma.Respiratory research · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ziming ChengDepartment of Thoracic Surgery, Linyi Central Hospital , Linyi , China.
Xiufeng LiDepartment of Thoracic Surgery, Linyi Central Hospital , Linyi , China.
Shizhen HouDepartment of Thoracic Surgery, Linyi Central Hospital , Linyi , China.ORCID http://orcid.org/0000-0003-4898-5315
Yubing WuDepartment of Thoracic Surgery, Linyi Central Hospital , Linyi , China.
Yi SunDepartment of Thoracic Surgery, Linyi Central Hospital , Linyi , China.
Bing LiuDepartment of Thoracic Surgery, Linyi Central Hospital , Linyi , China.
Linyi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Line, TumorCell SurvivalGene Knockdown TechniquesHistonesHumansLung NeoplasmsMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3p300-CBP-Associated Factorp300-CBP Transcription FactorsProto-Oncogene Proteins c-mdm2Proto-Oncogene Proteins p21(ras)SirtuinsHistonesKRAS protein, humanMDM2 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3p300-CBP-Associated Factorp300-CBP Transcription FactorsProto-Oncogene Proteins c-mdm2Proto-Oncogene Proteins p21(ras)SIRT7 protein, humanSirtuinscell proliferationERK1/2 downstream factorsK-RasmigrationNCI-H2126 cells

Identifiers

PMID31613681
PMCPMC6807650
OpenAlexW2980882443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.